| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 85186 |
花生四烯酸脂质体,liposomes,containing,arachidonic,acid,,Lipo-DAPE,脂质体纳米载体定制服务 |
179 |
axc |
2024-12-18 |
| 85187 |
SG3376, ADC试剂 |
145 |
kx |
2024-12-18 |
| 85188 |
Boc-Val-Ala-OH(CAS号:70396-18-8) |
179 |
WYQ |
2024-12-18 |
| 85189 |
Boc-Val-Ala-PAB(CAS号:1884577-99-4) |
203 |
WYQ |
2024-12-18 |
| 85190 |
鬼臼毒素脂质体(POD-Lps)多功能载药脂质体定制服务 |
193 |
axc |
2024-12-18 |
| 85191 |
HA-ASP-CH2-Gd-DOTA 透明质酸为载体的靶向肿瘤的大分子T1钆基造影剂 |
236 |
h |
2024-12-18 |
| 85192 |
DOTA-SC691-Br,DOTA偶联卤素取代物 |
174 |
h |
2024-12-18 |
| 85193 |
小檗碱共载脂质体(Lip-MB),载药脂质体定制服务 |
196 |
axc |
2024-12-18 |
| 85194 |
Maleimide-(CH2)5-COONHS cas:55750-63-5 6-(马来酰亚胺基)己酸琥珀酰亚胺酯 |
173 |
zyl |
2024-12-18 |
| 85195 |
DOTA-cetuximab DOTA-西妥昔单抗 |
251 |
h |
2024-12-18 |
| 85196 |
DOTA-CAIX-P1-4-10 大环配体DOTA修饰靶向碳酸酐酶IX的多肽探针 |
173 |
h |
2024-12-18 |
| 85197 |
三七皂苷脂质体,PNS-Lip,靶向脂质体定制服务 |
180 |
axc |
2024-12-18 |
| 85198 |
HS-C15-COOH 巯基-C15-羧基 |
318 |
zyl |
2024-12-18 |
| 85199 |
MC-VC-PAB-N3, ADC试剂 |
317 |
kx |
2024-12-18 |
| 85200 |
DSPE-PEG-四氮杂环配体 DSPE-PEG-tetranitroheterocyclic ligand DSPE-PEG-DOTA |
185 |
h |
2024-12-18 |
| 85201 |
1639939-40-4,MC-Val-Ala-PAB-PNP,ADC定制 |
183 |
wyh |
2024-12-18 |
| 85202 |
丝裂霉素C-全氟溴辛烷脂质体,PFOB@Lip-MMC,提供荧光脂质体定制服务 |
169 |
axc |
2024-12-18 |
| 85203 |
HS-(CH2)5-EG2-Biotin 巯基-五烷烃-二聚乙二醇-生物素 |
141 |
zyl |
2024-12-18 |
| 85204 |
MA-PEG4-Ala-Ala-PAB-PNP,MA-四聚乙二醇-ALA-ALA-PAB-PNP |
224 |
kx |
2024-12-18 |
| 85205 |
Ac-Nle-Asp-His-D-Phe-Arg-Trp-Gly-Lys(DOTA)-NH2 |
158 |
h |
2024-12-18 |
| 85206 |
1020112-73-5,2-氨基-1,3-双(羧乙氧基)丙烷盐酸盐,ADC定制 |
151 |
wyh |
2024-12-18 |
| 85207 |
DOTA-8-Aoc-BBN(7-14)NH2 |
132 |
h |
2024-12-18 |
| 85208 |
Fmoc-PEG4-Val-Ala-PAB,一种肽合成中常用的保护基 |
190 |
WYQ |
2024-12-18 |
| 85209 |
盐酸多柔比星脂质体,DOX-Lip,脂质体纳米载体定制服务 |
244 |
axc |
2024-12-18 |
| 85210 |
Gd-DOTA偶联甘草次酸(GGD) |
219 |
h |
2024-12-18 |
| 85211 |
HS-(CH2)3-EG12-OCH2-COOH 巯基-3烷烃-十二聚乙二醇-OCH2-羧基 |
210 |
zyl |
2024-12-18 |
| 85212 |
cas:2055024-55-8,Boc-PEG2-Val-Cit-PAB-OH,ADC定制 |
165 |
wyh |
2024-12-18 |
| 85213 |
阿仑膦酸钠(ALN)脂质体,多功能载药脂质体定制服务 |
413 |
axc |
2024-12-18 |
| 85214 |
KGDS多肽修饰的人铁蛋白负载DOTA KGDS-FRT-DOTA |
169 |
h |
2024-12-18 |
| 85215 |
Fmoc-Val-Ala-PAB-PNP,CAS号:1394238-92-6 |
180 |
WYQ |
2024-12-18 |
| 85216 |
钆卟啉(Gd-TP)负载石墨烯量子点修饰环肽RGD |
156 |
h |
2024-12-18 |
| 85217 |
Fmoc-Phe-Lys(Boc)-PAB, ADC试剂 |
137 |
kx |
2024-12-18 |
| 85218 |
HS-(CH2)11-EG2-NH3+ Cl- 巯基-十一烷烃-二聚乙二醇-NH3+ Cl- |
174 |
zyl |
2024-12-18 |
| 85219 |
顺铂脂质复合物脂质体,CDDP-MM,载药脂质体定制服务 |
142 |
axc |
2024-12-18 |
| 85220 |
MWCNT/PEI-FI-DOTA(Gd)-mPEG5K |
158 |
h |
2024-12-18 |
| 85221 |
Fmoc-PEG4-Val-Ala-PAB-PNP,一种高效且可控的多肽合成技术 |
195 |
WYQ |
2024-12-18 |
| 85222 |
寡聚透明质酸修饰的鞣花酸脂质体,EA-HA-L,靶向脂质体定制服务 |
222 |
axc |
2024-12-18 |
| 85223 |
Boc-PEG4-Val-Ala-PAB,一种可降解的ADC连接体 |
226 |
WYQ |
2024-12-18 |
| 85224 |
双-甲苯磺酸-(2-羟乙基二硫化物),Bis-Tos-(2-hydroxyethyl disulfide),ADC定制 |
208 |
wyh |
2024-12-18 |
| 85225 |
Fmoc-Arg(boc)2-PAB-OH, ADC试剂 |
206 |
kx |
2024-12-18 |
| 85226 |
Boc-Val-Ala-PAB-PNP,CAS号:1884578-00-0 |
130 |
WYQ |
2024-12-18 |
| 85227 |
中性粒细胞膜修饰吲哚菁绿脂质体纳米探针,Neu-Lipo-ICG,提供荧光脂质体定制服务 |
307 |
axc |
2024-12-18 |
| 85228 |
864235-83-6,Fmoc-NH-ethyl-SS-propionic acid,ADC定制 |
156 |
wyh |
2024-12-18 |
| 85229 |
Boc-PEG4-Val-Ala-PAB-PNP,1884578-00-0 |
151 |
WYQ |
2024-12-18 |
| 85230 |
159857-70-2,MC-Val-Cit-Doxorubicin,MC-VAL-CIT-阿霉素 |
215 |
kx |
2024-12-18 |